Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1

Conditions

Leukemia, Myeloid, Acute 151Leukemia 67Precursor Cell Lymphoblastic Leukemia-Lymphoma 29Leukemia, Myelomonocytic, Acute 26Leukemia, Monocytic, Acute 26Myelodysplastic Syndromes 24Leukemia, Erythroblastic, Acute 23Leukemia, Megakaryoblastic, Acute 22Congenital Abnormalities 21Leukemia, Promyelocytic, Acute 13Leukemia, Myelomonocytic, Chronic 12Anemia, Refractory, with Excess of Blasts 12Recurrence 8Leukemia, Myelogenous, Chronic, BCR-ABL Positive 8Myeloproliferative Disorders 7Leukemia, Myeloid, Chronic-Phase 7Leukemia, Eosinophilic, Acute 7Leukemia, Biphenotypic, Acute 7Leukemia, Basophilic, Acute 6Blast Crisis 6Neoplasm, Residual 4Neutropenia 3Lymphoma 3Leukemia, Myeloid, Accelerated Phase 3Leukemia, Myeloid 3Neoplasms 2Myelodysplastic-Myeloproliferative Diseases 2Lymphoma, Follicular 2Lymphoma, B-Cell, Marginal Zone 2Leukemia, T-Cell 2

Interventions

Cytarabine 5Vincristine 3Thioguanine 3Methotrexate 3Mercaptopurine 3Daunorubicin 3Cyclophosphamide 3prednylidene 2pegaspargase 2merphos 2dexamethasone acetate 2dexamethasone 21-phosphate 2azathiopurine 2auricularum 2asparaginase erwinia chrysanthemi recombinant 2Prednisolone 2Leucovorin 2Etoposide 2Doxorubicin 2Dexamethasone 2Calcium Dobesilate 2Asparaginase 2deltacortene 1blinatumomab 1Radiotherapy 1Radiation 1Prednisone 1N,N-dicyclohexyl-isoborneol-10-sulfonamide 1Mitoxantrone 1Methylprednisolone 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Down Syndrome × Idarubicin × Other hematologic neoplasm × Clear all
NCT07232134 2025-11-20

AML-DS-2025

Federal Research Institute of Pediatric Hematology, Oncology and Immunology

Phase 3 Recruiting
100 enrolled
Other hematologic neoplasm

Down Syndrome, Leukemia, Myeloid, Acute

Data powered by HemOnc (CC BY 4.0) Colophon âš¡